RxDoctor Payments Data

Mason Qualls, MD

Psychiatry · Tampa, FLNPI 1841751351

Payments from drug & device makers

$5,504in general payments, 2019–2025

Across 258 payments — averaging $21.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$712
  • Johnson & Johnson$674
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$625
  • Alkermes, Inc.$347
  • AbbVie$345
  • Noven Therapeutics, LLC$316
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$5,504100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,504 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$87,274
Medicare patients
126
Services billed
851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate21$197,415
AustedoDeutetrabenazine12$87,185
AuvelityDextromethorphan Hbr/Bupropion24$27,553
TrintellixVortioxetine Hydrobromide23$19,961
FanaptIloperidone13$13,623
BelsomraSuvorexant26$8,639
Aripiprazole69$8,385
Dyanavel XrAmphetamine13$5,611
DayvigoLemborexant13$4,880
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine83$4,303
Buspirone Hcl151$3,416
Asenapine Maleate12$3,143
Bupropion XlBupropion Hcl133$3,142
Duloxetine Hcl94$2,915
Venlafaxine Hcl ErVenlafaxine Hcl52$2,872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$261$197,41521 claims
Teva Pharmaceuticals USA, Inc.Austedo$230$87,18512 claims
Axsome Therapeutics, Inc.Auvelity$238$27,55324 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$260$19,96123 claims
Vanda Pharmaceuticals Inc.Fanapt$127$13,62313 claims
Tris Pharma IncDyanavel Xr$144$5,61113 claims
Eisai Inc.Dayvigo$90$4,88013 claims
Almatica Pharma LLCSertraline Hcl$276$81097 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →